info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Deficiency of other/unspecified vitamins

E4_VIT_NAS_DEF

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E56.8, E56.9
  • Hospital discharge: ICD-9 269[1-2]
  • Hospital discharge: ICD-8 266[8-9]
  • Hospital discharge: excluded ICD-8 26688
  • Cause of death: ICD-10 E56.8, E56.9
  • Cause of death: ICD-9 269[1-2]
  • Cause of death: ICD-8 266[8-9]
  • Cause of death: excluded ICD-8 26688

2 out of 7 registries used, show all original rules.

51

4. Check minimum number of events

None

51

5. Include endpoints

None

51

6. Filter based on genotype QC (FinnGen only)

48

Control definitions (FinnGen only)

Control exclude
E4_NUTRIDEF

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 344 188 154
Only index persons 302 165 137
Unadjusted period prevalence (%)
Whole population 0.00 0.01 0.00
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 60.93 59.56 62.55
Only index persons 61.44 59.66 63.58

-FinnGen-

Key figures

All Female Male
Number of individuals 48 26 22
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 62.28 59.26 65.84

-FinRegistry-

Age distribution of first events

0102030405060708090051015202530354045505560AgeIndividuals

-FinnGen-

Age distribution of first events

02040607080012345678910111213AgeIndividuals

-FinRegistry-

Year distribution of first events

197019801985199019952000200520102015202020220102030405060708090100110YearIndividuals

-FinnGen-

Year distribution of first events

197019751980199020102015202020250246810121416YearIndividuals

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
51
Matched controls
510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
59.6
45
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
50.8
40
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
47.5
38
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
47.5
38
*
J01DB01, ,
ATC
cefalexin; oral
+∞
45.9
37
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
42.9
35
*
E568, ,
ICD-10 Finland
Deficiency of other vitamins
+∞
39.9
33
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
38.5
32
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
38.5
32
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
32.9
28
*
J01DA01, ,
ATC
[U] cefalexin
+∞
32.9
28
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
32.9
28
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
31.5
27
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
31.5
27
*
WX110, ,
ICD-O-3
+∞
31.5
27
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
30.2
26
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
28.9
25
*
SAA01, ,
ICD-O-3
+∞
28.9
25
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
27.6
24
*
M03BX02, ,
ATC
tizanidine; oral
+∞
26.3
23
*
R06AE07, ,
ATC
cetirizine; oral
+∞
26.3
23
*
UJD10, ,
ICD-O-3
+∞
26.3
23
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
25.1
22
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
25.1
22
*
K021, ,
ICD-O-3
+∞
25.1
22
*
GD1AA, ,
ICD-O-3
+∞
25.1
22
*
EB1AA, ,
ICD-O-3
+∞
23.8
21
*
S18, ,
ICD-O-3
+∞
23.8
21
*
SAA02, ,
ICD-O-3
+∞
22.6
20
*
SFA10, ,
ICD-O-3
+∞
22.6
20
*
SPAT1256, ,
ICD-O-3
+∞
22.6
20
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
22.6
20
*
WZC00, ,
ICD-O-3
+∞
21.3
19
*
WX290, ,
ICD-O-3
+∞
21.3
19
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
21.3
19
*
SFA20, ,
ICD-O-3
+∞
21.3
19
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
21.3
19
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
21.3
19
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
20.1
18
*
SPAT1263, ,
ICD-O-3
+∞
20.1
18
*
ZXE00, ,
ICD-O-3
+∞
20.1
18
*
SPAT1249, ,
ICD-O-3
+∞
20.1
18
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
20.1
18
*
SPAT1253, ,
ICD-O-3
+∞
20.1
18
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
20.1
18
*
C03CA01, ,
ATC
furosemide; systemic
+∞
20.1
18
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
20.1
18
*
M02AA07, ,
ATC
piroxicam; topical
+∞
18.9
17
*
A10BA02, ,
ATC
metformin; oral
+∞
18.9
17
*
SPAT1310, ,
ICD-O-3
+∞
18.9
17
*
N06AB04, ,
ATC
citalopram; systemic
+∞
18.9
17
*
AA1AD, ,
ICD-O-3
+∞
18.9
17
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
18.9
17
*
C10AA01, ,
ATC
simvastatin; oral
+∞
18.9
17
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
17.7
16
*
SPAT1223, ,
ICD-O-3
+∞
17.7
16
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
17.7
16
*
ZXE10, ,
ICD-O-3
+∞
17.7
16
*
WYA05, ,
ICD-O-3
+∞
17.7
16
*
I10, ,
ICD-O-3
+∞
17.7
16
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
16.5
15
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
16.5
15
*
SAA03, ,
ICD-O-3
+∞
16.5
15
*
Z012, ,
ICD-O-3
+∞
16.5
15
*
L28, ,
ICD-O-3
+∞
16.5
15
*
EB1SA, ,
ICD-O-3
+∞
16.5
15
*
EBA00, ,
ICD-O-3
+∞
16.5
15
*
SPAT1216, ,
ICD-O-3
+∞
16.5
15
*
GD1QA, ,
ICD-O-3
+∞
16.5
15
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
16.5
15
*
N05AH04, ,
ATC
quetiapine; oral
+∞
16.5
15
*
C09CA06, ,
ATC
candesartan; oral
+∞
16.5
15
*
ZXD05, ,
ICD-O-3
+∞
15.4
14
*
R4110, ,
ICD-O-3
+∞
15.4
14
*
Z2221, ,
ICD-O-3
+∞
15.4
14
*
N05BA04, ,
ATC
oxazepam; oral
+∞
15.4
14
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
15.4
14
*
SPAT1250, ,
ICD-O-3
+∞
15.4
14
*
CJE20, ,
ICD-O-3
+∞
15.4
14
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
15.4
14
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
15.4
14
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
15.4
14
*
C07AA05, ,
ATC
propranolol; systemic
+∞
15.4
14
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
15.4
14
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
15.4
14
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
15.4
14
*
J069, ,
ICD-O-3
+∞
15.4
14
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
15.4
14
*
EB1HA, ,
ICD-O-3
+∞
15.4
14
*
SPAT1153, ,
ICD-O-3
+∞
15.4
14
*
R74, ,
ICD-O-3
+∞
15.4
14
*
SPAT1312, ,
ICD-O-3
+∞
14.2
13
*
Z871, ,
ICD-O-3
+∞
14.2
13
*
LC2BE, ,
ICD-O-3
+∞
14.2
13
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
14.2
13
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
14.2
13
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
14.2
13
*
M796, ,
ICD-O-3
+∞
14.2
13
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
14.2
13
*
C08CA01, ,
ATC
amlodipine; oral
+∞
14.2
13
*
T90, ,
ICD-O-3
+∞
14.2
13
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
14.2
13
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
14.2
13
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
14.2
13
*
ZXD10, ,
ICD-O-3
+∞
14.2
13
*
B03BA03, ,
ATC
hydroxocobalamin; parenteral
+∞
14.2
13
*
Z3231, ,
ICD-O-3
+∞
13.1
12
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
13.1
12
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
13.1
12
*
L03, ,
ICD-O-3
+∞
13.1
12
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
13.1
12
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
13.1
12
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
13.1
12
*
D07AC01, ,
ATC
betamethasone; topical
+∞
13.1
12
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
13.1
12
*
A28, ,
ICD-O-3
+∞
13.1
12
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
13.1
12
*
N03AX16, ,
ATC
[U] pregabalin
+∞
13.1
12
*
E0000UV, ,
ATC
+∞
13.1
12
*
ZXA00, ,
ICD-O-3
+∞
13.1
12
*
R05, ,
ICD-O-3
+∞
13.1
12
*
KMAK, ,
ICD-O-3
+∞
13.1
12
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
13.1
12
*
N06AB10, ,
ATC
escitalopram; oral
+∞
13.1
12
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
13.1
12
*
-1, ,
ICD-O-3
+∞
13.1
12
*
A06AD11, ,
ATC
lactulose; oral
+∞
11.9
11
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
11.9
11
*
SPAT1254, ,
ICD-O-3
+∞
11.9
11
*
R06AX27, ,
ATC
desloratadine; oral
+∞
11.9
11
*
K045, ,
ICD-O-3
+∞
11.9
11
*
N06AX21, ,
ATC
duloxetine; oral
+∞
11.9
11
*
Z3226, ,
ICD-O-3
+∞
11.9
11
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
11.9
11
*
N05CF01, ,
ATC
zopiclone; oral
+∞
11.9
11
*
SPAT1148, ,
ICD-O-3
+∞
11.9
11
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
11.9
11
*
E569, ,
ICD-10 Finland
Vitamin deficiency, unspecified
+∞
11.9
11
*
WX408, ,
ICD-O-3
+∞
11.9
11
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
11.9
11
*
SDA02, ,
ICD-O-3
+∞
11.9
11
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
11.9
11
*
ZXA05, ,
ICD-O-3
+∞
11.9
11
*
R5110, ,
ICD-O-3
+∞
11.9
11
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
11.9
11
*
SPAT1230, ,
ICD-O-3
+∞
11.9
11
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
10.8
10
*
XF400, ,
ICD-O-3
+∞
10.8
10
*
SPAT1262, ,
ICD-O-3
+∞
10.8
10
*
XCK10, ,
ICD-O-3
+∞
10.8
10
*
SPAT1222, ,
ICD-O-3
+∞
10.8
10
*
SPAT1301, ,
ICD-O-3
+∞
10.8
10
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
10.8
10
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
10.8
10
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
10.8
10
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
10.8
10
*
B81, ,
ICD-O-3
+∞
10.8
10
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
10.8
10
*
SPAT1149, ,
ICD-O-3
+∞
10.8
10
*
R01AD09, ,
ATC
mometasone; nasal
+∞
10.8
10
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
10.8
10
*
JN3AE, ,
ICD-O-3
+∞
10.8
10
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
10.8
10
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
10.8
10
*
SFC01, ,
ICD-O-3
+∞
10.8
10
*
M545, ,
ICD-O-3
+∞
10.8
10
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
10.8
10
*
N05AX08, ,
ATC
risperidone; systemic
+∞
10.8
10
*
L17, ,
ICD-O-3
+∞
10.8
10
*
N06AA09, ,
ATC
amitriptyline; systemic
+∞
10.8
10
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
10.8
10
*
WZB00, ,
ICD-O-3
+∞
9.7
9
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
9.7
9
*
N05CD07, ,
ATC
temazepam; oral
+∞
9.7
9
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
9.7
9
*
C09CA01, ,
ATC
losartan; oral
+∞
9.7
9
*
SCA01, ,
ICD-O-3
+∞
9.7
9
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
9.7
9
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
9.7
9
*
SPAT1053, ,
ICD-O-3
+∞
9.7
9
*
Z712, ,
ICD-O-3
+∞
9.7
9
*
Z760, ,
ICD-O-3
+∞
9.7
9
*
CK2S4, ,
ICD-O-3
+∞
9.7
9
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
9.7
9
*
FM1AE, ,
ICD-O-3
+∞
9.7
9
*
SPAT1240, ,
ICD-O-3
+∞
9.7
9
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
9.7
9
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
9.7
9
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
9.7
9
*
R568, ,
ICD-10 Finland
Other and unspecified convulsions
+∞
9.7
9
*
B01AA03, ,
ATC
warfarin; systemic
+∞
9.7
9
*
FM1EE, ,
ICD-O-3
+∞
9.7
9
*
D07AC13, ,
ATC
mometasone; topical
+∞
9.7
9
*
R21, ,
ICD-O-3
+∞
9.7
9
*
R03DC03, ,
ATC
montelukast; oral
+∞
9.7
9
*
TPH04, ,
ICD-O-3
+∞
9.7
9
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
9.7
9
*
S29, ,
ICD-O-3
+∞
9.7
9
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
9.7
9
*
I48, ,
ICD-O-3
+∞
8.6
8
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
8.6
8
*
SDA03, ,
ICD-O-3
+∞
8.6
8
*
D19, ,
ICD-O-3
+∞
8.6
8
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
8.6
8
*
M545, ,
ICD-10 Finland
Low back pain
+∞
8.6
8
*
ZXA10, ,
ICD-O-3
+∞
8.6
8
*
R83, ,
ICD-O-3
+∞
8.6
8
*
SPAT1229, ,
ICD-O-3
+∞
8.6
8
*
M255, ,
ICD-O-3
+∞
8.6
8
*
WX002, ,
ICD-O-3
+∞
8.6
8
*
J010, ,
ICD-O-3
+∞
8.6
8
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
8.6
8
*
UJF32, ,
ICD-O-3
+∞
8.6
8
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
8.6
8
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
8.6
8
*
JN3AD, ,
ICD-O-3
+∞
8.6
8
*
N06AB06, ,
ATC
sertraline; oral
+∞
8.6
8
*
R53, ,
ICD-O-3
+∞
8.6
8
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
8.6
8
*
D82, ,
ICD-O-3
+∞
8.6
8
*
S060, ,
ICD-10 Finland
Concussion
+∞
8.6
8
*
E000001, ,
ATC
+∞
8.6
8
*
WX700, ,
ICD-O-3
+∞
8.6
8
*
M544, ,
ICD-O-3
+∞
8.6
8
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
8.6
8
*
SFA30, ,
ICD-O-3
+∞
8.6
8
*
UJF30, ,
ICD-O-3
+∞
8.6
8
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
8.6
8
*
SPAT1156, ,
ICD-O-3
+∞
8.6
8
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
8.6
8
*
SPAT1306, ,
ICD-O-3
+∞
7.5
7
*
ZXE02, ,
ICD-O-3
+∞
7.5
7
*
E11, ,
ICD-O-3
+∞
7.5
7
*
M01AX05, ,
ATC
glucosamine; oral
+∞
7.5
7
*
D07AB08, ,
ATC
desonide; topical
+∞
7.5
7
*
Z3229, ,
ICD-O-3
+∞
7.5
7
*
SPAT1260, ,
ICD-O-3
+∞
7.5
7
*
E119, ,
ICD-O-3
+∞
7.5
7
*
F322, ,
ICD-10 Finland
Severe depressive episode without psychotic symptoms
+∞
7.5
7
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
7.5
7
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
7.5
7
*
SPAT1281, ,
ICD-O-3
+∞
7.5
7
*
C09AA05, ,
ATC
ramipril; oral
+∞
7.5
7
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
7.5
7
*
WZC30, ,
ICD-O-3
+∞
7.5
7
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
7.5
7
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
7.5
7
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
7.5
7
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
7.5
7
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
7.5
7
*
L12, ,
ICD-O-3
+∞
7.5
7
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
7.5
7
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
7.5
7
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
7.5
7
*
WX404, ,
ICD-O-3
+∞
7.5
7
*
A10AC01, ,
ATC
insulin (human); parenteral
+∞
7.5
7
*
Z016, ,
ICD-O-3
+∞
7.5
7
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
7.5
7
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
7.5
7
*
N05BA12, ,
ATC
alprazolam; oral
+∞
7.5
7
*
WZA90, ,
ICD-O-3
+∞
7.5
7
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
7.5
7
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
7.5
7
*
SPAT1033, ,
ICD-O-3
+∞
7.5
7
*
J459, ,
ICD-O-3
+∞
7.5
7
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
7.5
7
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
7.5
7
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
7.5
7
*
GD1PA, ,
ICD-O-3
+∞
7.5
7
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
7.5
7
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
7.5
7
*
K0364, ,
ICD-O-3
+∞
7.5
7
*
R11, ,
ICD-10 Finland
Nausea and vomiting
+∞
7.5
7
*
SDA04, ,
ICD-O-3
+∞
7.5
7
*
SFA40, ,
ICD-O-3
+∞
7.5
7
*
R02, ,
ICD-O-3
+∞
7.5
7
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
7.5
7
*
JKA21, ,
ICD-O-3
+∞
7.5
7
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
7.5
7
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
6.4
6
*
SPAT1325, ,
ICD-O-3
+∞
6.4
6
*
KC1EE, ,
ICD-O-3
+∞
6.4
6
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
6.4
6
*
Z718, ,
ICD-O-3
+∞
6.4
6
*
R238, ,
ICD-O-3
+∞
6.4
6
*
L13, ,
ICD-O-3
+∞
6.4
6
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
6.4
6
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
6.4
6
*
H811, ,
ICD-O-3
+∞
6.4
6
*
F101, ,
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
+∞
6.4
6
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
6.4
6
*
SPAT1245, ,
ICD-O-3
+∞
6.4
6
*
F29, ,
ICD-O-3
+∞
6.4
6
*
SPAT1211, ,
ICD-O-3
+∞
6.4
6
*
D01BA02, ,
ATC
terbinafine; oral
+∞
6.4
6
*
JN4BD, ,
ICD-O-3
+∞
6.4
6
*
GD1UA, ,
ICD-O-3
+∞
6.4
6
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
6.4
6
*
SPAT1283, ,
ICD-O-3
+∞
6.4
6
*
P01, ,
ICD-O-3
+∞
6.4
6
*
H02AB07, ,
ATC
prednisone; oral
+∞
6.4
6
*
Z027, ,
ICD-O-3
+∞
6.4
6
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
6.4
6
*
N05CF02, ,
ATC
zolpidem; oral
+∞
6.4
6
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
6.4
6
*
L01, ,
ICD-O-3
+∞
6.4
6
*
XPX99, ,
ICD-O-3
+∞
6.4
6
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
6.4
6
*
NF1AA, ,
ICD-O-3
+∞
6.4
6
*
N06CA01, ,
ATC
amitriptyline and psycholeptics; systemic
+∞
6.4
6
*
R03AC12, ,
ATC
salmeterol; inhalant
+∞
6.4
6
*
H81, ,
ICD-O-3
+∞
6.4
6
*
M01AH01, ,
ATC
celecoxib; oral
+∞
6.4
6
*
112, ,
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
6.4
6
*
R104, ,
ICD-O-3
+∞
6.4
6
*
N06AX12, ,
ATC
bupropion; oral
+∞
6.4
6
*
NH3AA, ,
ICD-O-3
+∞
6.4
6
*
B01AF02, ,
ATC
apixaban; oral
+∞
6.4
6
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
6.4
6
*
SPAT1137, ,
ICD-O-3
+∞
6.4
6
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
6.4
6
*
UDC00, ,
ICD-O-3
+∞
6.4
6
*
R06AX13, ,
ATC
loratadine; oral
+∞
6.4
6
*
H13, ,
ICD-O-3
+∞
6.4
6
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
6.4
6
*
R5180, ,
ICD-10 Finland
Headache
+∞
6.4
6
*
SGA01, ,
ICD-O-3
+∞
6.4
6
*
ZXE03, ,
ICD-O-3
+∞
6.4
6
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
6.4
6
*
WW200, ,
ICD-O-3
+∞
6.4
6
*
K219, ,
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
+∞
6.4
6
*
ZXE05, ,
ICD-O-3
+∞
6.4
6
*
SBB00, ,
ICD-O-3
+∞
6.4
6
*
EBA05, ,
ICD-O-3
+∞
6.4
6
*
R01AD05, ,
ATC
budesonide; nasal
+∞
6.4
6
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
6.4
6
*
E117, ,
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
+∞
6.4
6
*
L08, ,
ICD-O-3
+∞
6.4
6
*
A04, ,
ICD-O-3
+∞
6.4
6
*
E6601, ,
ICD-10 Finland
Obesity due to excess calories
+∞
6.4
6
*
D07AD01, ,
ATC
clobetasol; topical
+∞
6.4
6
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
6.4
6
*
WX892, ,
ICD-O-3
+∞
6.4
6
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
6.4
6
*
SGA02, ,
ICD-O-3
+∞
6.4
6
*
I509, ,
ICD-O-3
+∞
6.4
6
*
F419, ,
ICD-10 Finland
Anxiety disorder, unspecified
+∞
6.4
6
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
6.4
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
60
4.84
6.55
3.0
1.6
1553.36
1115.16
nmol/l
0.86
14
49
28
124
3.79
5.21
2.3
1.9
74.25
91.02
pmol/l
1.18
15
55
32
170
3.37
4.23
11.4
6.1
1.18
1.22
mmol/l
1.58
24
145
14
44
4.01
4.14
1.3
1.2
—
—
—
0
0
12
32
4.58
3.69
8.3
2.6
—
—
—
0
0
20
97
2.75
2.87
8.3
4.0
—
—
—
0
0
12
41
3.51
2.87
3.2
1.5
—
—
—
0
0
18
84
2.77
2.76
10.0
4.0
—
—
—
0
0
7
16
4.89
2.57
3.1
3.1
—
—
—
0
0
25
142
2.49
2.56
8.9
4.0
42.06
55.38
ng/l
0.17
18
91
10
35
3.30
2.37
5.9
4.2
—
—
—
0
0
17
85
2.50
2.23
4.0
3.3
120.23
58.59
mg/l
—
10
56
10
38
3.02
2.15
11.3
5.2
103.00
105.58
mmol/l
—
10
38
18
94
2.41
2.14
5.0
3.9
33.38
9.54
mg/mmol
0.58
12
58
8
27
3.32
2.03
15.6
5.4
—
—
—
0
0
7
23
3.36
1.87
3.3
1.8
195.00
124.89
ng/l
—
7
18
5
12
4.49
1.87
9.4
3.0
25.22
24.57
mmol/l
—
5
12
38
285
2.31
1.81
5.3
4.4
15.33
11.40
mm/h
1.04
33
257
5
13
4.14
1.76
2.6
3.5
25.36
23.48
mmol/l
—
5
13
11
50
2.53
1.71
7.0
1.9
—
—
—
0
0
5
14
3.84
1.65
9.4
2.6
0.80
0.70
%
—
5
14
18
108
2.03
1.48
3.8
2.0
—
—
—
0
0
5
16
3.34
1.47
9.4
2.5
1.94
2.31
%
—
5
16
6
23
2.82
1.41
2.0
1.2
—
—
—
0
0
19
119
1.95
1.37
5.6
3.3
—
—
—
0
0
17
106
1.91
1.23
6.4
3.2
7.39
7.39
ph
—
9
17
6
26
2.48
1.22
1.7
1.4
—
—
—
0
0
8
40
2.18
1.18
2.9
2.0
—
—
—
0
0
24
170
1.78
1.15
15.8
9.8
1.21
1.24
inr
—
10
53
25
186
1.67
0.97
9.0
6.5
7.92
8.90
%
0.72
20
172
24
177
1.67
0.96
11.0
7.0
—
—
—
0
0
6
28
2.29
0.95
1.3
1.6
—
—
—
0
0
32
257
1.66
0.90
8.0
4.7
—
—
—
0
0
6
30
2.13
0.90
1.8
1.3
—
—
—
0
0
8
45
1.92
0.89
2.9
1.8
33.88
28.24
s
—
8
45
14
91
1.74
0.86
4.0
2.7
318.86
342.29
umol/l
0.36
14
77
6
33
1.92
0.82
6.2
4.1
—
—
—
0
0
43
380
1.84
0.77
39.4
12.6
20.83
20.18
mg/l
0.06
36
290
14
95
1.65
0.74
1.4
1.3
1.13
1.23
u/ml
—
6
21
7
43
1.73
0.70
2.9
1.3
—
—
—
0
0
38
329
1.61
0.70
8.8
4.9
45.82
39.52
mmol/mol
1.53
33
300
15
106
1.59
0.67
3.1
3.0
—
—
—
0
0
9
60
1.61
0.59
4.2
2.0
9.09
14.07
umol/l
—
9
55
6
37
1.70
0.58
1.3
1.2
—
—
—
0
0
6
37
1.70
0.58
2.7
1.5
—
—
—
0
0
6
38
1.65
0.56
1.0
1.3
—
—
—
0
0
18
139
1.46
0.54
2.2
1.9
—
—
—
0
0
22
180
1.39
0.47
7.0
4.0
0.00
0.00
estimate
—
7
38
38
342
1.44
0.45
4.1
3.7
1.39
1.25
mmol/l
0.59
33
314
5
31
1.68
0.44
1.0
1.3
—
—
—
0
0
14
108
1.41
0.41
7.9
3.8
—
—
—
0
0
21
179
1.29
0.32
11.9
5.6
0.00
0.00
estimate
—
6
34
8
64
1.30
0.29
1.9
1.7
—
—
—
0
0
21
182
1.26
0.27
7.0
4.0
0.00
0.00
estimate
—
5
35
12
98
1.29
0.24
2.5
4.7
2.34
1.93
ug/l
0.21
12
87
42
398
1.31
0.23
38.1
14.5
86.40
75.60
umol/l
0.69
42
398
5
41
1.24
0.22
1.4
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
404.16
—
0
5
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
8.2
—
—
—
0
0
42
403
1.24
0.14
40.4
11.5
—
—
—
0
0
12
104
1.20
0.14
4.6
4.0
0.00
0.00
estimate
—
6
33
5
45
1.12
0.10
1.0
1.4
—
—
—
0
0
11
98
1.16
0.08
8.5
6.3
—
—
—
0
0
7
80
0.86
0.08
4.6
3.7
—
—
—
0
0
9
84
1.09
0.07
2.0
1.7
—
—
—
0
0
13
120
1.11
0.05
1.8
1.6
—
—
—
0
0
26
254
1.05
0.00
6.6
3.4
—
—
—
0
0
11
111
0.99
0.00
2.8
2.5
—
—
—
0
0
33
332
0.98
0.00
41.3
14.9
14.93
14.95
%
0.01
33
325
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
11.06
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
7.6
—
105.44
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
7.6
—
10.56
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint E4_VIT_NAS_DEF and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
E4_VIT_NAS_DEF 1.706 [0.86, 3.38] 0.125
Birth year 0.987 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 118 males with E4_VIT_NAS_DEF died.

Mortality risk

Mortality risk for people of age

years, who have E4_VIT_NAS_DEF.

N-year risk Females Males
1 No data 0.391%
5 No data 1.968%
10 No data 5.044%
15 No data 9.336%
20 No data 15.5%

Relationships between endpoints

Index endpoint: E4_VIT_NAS_DEF – Deficiency of other/unspecified vitamins

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data